Haqq Christopher's most recent trade in Elicio Therapeutics Inc. was a trade of 50,900 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Elicio Therapeutics Inc | Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 50,900 | 50,900 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc | Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Feb 2026 | 25,400 | 57,381 | - | 0 | Common Stock | |
| Elicio Therapeutics Inc | Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc | Christopher Haqq | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 28,200 | 28,200 | - | - | Stock Option (Right to Buy) | |
| Elicio Therapeutics Inc | Haqq Christopher | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 28,200 | 28,200 | - | - | Stock Option (right to buy) |